NCT00629343 2025-06-05Phase I Dose-Escalation Study Of Azacitidine In Combination With TemozolomideColumbia UniversityPhase 1 Completed27 enrolled 7 charts
NCT03150810 2024-12-20Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsBeiGenePhase 1 Completed139 enrolled 36 charts
NCT02511132 2022-12-22A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's SarcomaGradalis, Inc.Phase 2 Completed22 enrolled 13 charts
NCT01055314 2017-08-29Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic RhabdomyosarcomaNational Cancer Institute (NCI)Phase 2 Completed175 enrolled 13 charts